Eiko Lifesciences Shows Profit Surge Amid Shift to Mildly Bullish Market Signals
Eiko Lifesciences has recently adjusted its evaluation, reflecting a shift in technical trends. The company reported a significant 500% increase in profit before tax for the latest quarter, achieving a high operating profit to net sales ratio. Despite positive indicators, its long-term fundamental strength remains modest.
Eiko Lifesciences, a microcap company in the specialty chemicals industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in technical trends, indicating a transition from bearish to mildly bullish signals in certain metrics. The company's stock price currently stands at 54.22, up from a previous close of 51.81, with a 52-week high of 74.88 and a low of 42.00. Notably, Eiko Lifesciences has reported a significant growth in profit before tax, with a remarkable increase of 500% in the latest quarter, reaching Rs 1.20 crore. Additionally, the company achieved its highest operating profit to net sales ratio at 14.10%, showcasing operational efficiency.
Despite these positive indicators, Eiko Lifesciences has a long-term fundamental strength characterized by an average Return on Equity (ROE) of 2.82%. The stock is currently trading at a discount compared to its peers, with a PEG ratio of 0.7, suggesting a fair valuation relative to its growth prospects.
For those interested in tracking the latest developments, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
